1. Akdemir G, Ergungor MF, Sezer M, Albayrak L, Daglioglu E, Kilinc K. Therapeutic efficacy of intraventricular cyclosporine A and methylprednisolone on a global cerebral ischemia model in rats. Neurol Res. 2005 Dec;27(8):827-34.
2. Alonso D, Encinas JM, Uttenthal LO, Bosca L, Serrano J, Fernandez AP, et al. Coexistence of translocated cytochrome c and nitrated protein in neurons of the rat cerebral cortex after oxygen and glucose deprivation. Neuroscience. 2002;111(1):47-56.
3. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci. 1997 Sep 15;17(18):6939-46.
4. Domanska-Janik K, Buzanska L, Dluzniewska J, Kozlowska H, Sarnowska A, Zablocka B. Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm. Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):50-9.
5. Folbergrova J, Li PA, Uchino H, Smith ML, Siesjo BK. Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp Brain Res. 1997 Mar;114(1):44-50.
6. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J Neurosci. 1998 Jul 15;18(14):5151-9.
7. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie. 2002 Feb-Mar;84(2-3):241-50.
8. Hagl C, Tatton NA, Weisz DJ, Zhang N, Spielvogel D, Shiang HH, et al. Cyclosporine A as a potential neuroprotective agent: a study of prolonged hypothermic circulatory arrest in a chronic porcine model. Eur J Cardiothorac Surg. 2001 Jun;19(6):756-64.
9. Hailer NP. Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol. 2008 Mar;84(3):211-33.
10. Hwang JH, Lee JH, Lee KH, Bae EJ, Sung DK, Chang YS, et al. Cyclosporine A attenuates hypoxic-ischemic brain injury in newborn rats. Brain Res. Nov 4;1359:208-15.
11. Kaminska B, Gaweda-Walerych K, Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants--facts and hypotheses. J Cell Mol Med. 2004 Jan-Mar;8(1):45-58.
12. Kobayashi T, Kuroda S, Tada M, Houkin K, Iwasaki Y, Abe H. Calcium-induced mitochondrial swelling and cytochrome c release in the brain: its biochemical characteristics and implication in ischemic neuronal injury. Brain Res. 2003 Jan 17;960(1-2):62-70.
13. Kondo Y, Asanuma M, Iwata E, Kondo F, Miyazaki I, Ogawa N. Early treatment with cyclosporin A ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurochem Res. 1999 Jan;24(1):9-13.
14. Kondo Y, Ogawa N, Asanuma M, Nishibayashi S, Iwata E, Mori A. Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus. Neurosci Res. 1995 Mar;22(1):123-7.
15. Korde AS, Pettigrew LC, Craddock SD, Pocernich CB, Waldmeier PC, Maragos WF. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. J Neurotrauma. 2007 May;24(5):895-908.
16. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke. 1998 Mar;29(3):705-18.
17. Kuroda S, Siesjo BK. Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci. 1997;4(4):199-212.
18. Leger PL, De Paulis D, Branco S, Bonnin P, Couture-Lepetit E, Baud O, et al. Evaluation of cyclosporine A in a stroke model in the immature rat brain. Exp Neurol. Jun 16.
19. Li PA, He QP, Siesjo BK. Effects of intracarotid arterial injection of cyclosporin A and spontaneous hypothermia on brain damage incurred after a long period of global ischemia. Brain Res. 2001 Feb 2;890(2):306-13.
20. Li PA, Kristian T, He QP, Siesjo BK. Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp Neurol. 2000 Sep;165(1):153-63.
21. Li PA, Uchino H, Elmer E, Siesjo BK. Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia. Brain Res. 1997 Apr 4;753(1):133-40.
22. Liu RR, Murphy TH. Reversible cyclosporin A-sensitive mitochondrial depolarization occurs within minutes of stroke onset in mouse somatosensory cortex in vivo: a two-photon imaging study. J Biol Chem. 2009 Dec 25;284(52):36109-17.
23. Liu XD, Pan GY, Xie L, Hou YY, Lan W, Su Q, et al. Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats. Acta Pharmacol Sin. 2002 Mar;23(3):225-9.
24. Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1999 Jul;19(7):736-41.
25. Miyata K, Omori N, Uchino H, Yamaguchi T, Isshiki A, Shibasaki F. Involvement of the brain-derived neurotrophic factor/TrkB pathway in neuroprotecive effect of cyclosporin A in forebrain ischemia. Neuroscience. 2001;105(3):571-8.
26. Morioka M, Hamada J, Ushio Y, Miyamoto E. Potential role of calcineurin for brain ischemia and traumatic injury. Prog Neurobiol. 1999 May;58(1):1-30.
27. Muramatsu Y, Furuichi Y, Tojo N, Moriguchi A, Maemoto T, Nakada H, et al. Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models. Brain Res. 2007 May 29;1149:181-90.
28. Murozono M, Matsumoto S, Matsumoto E, Isshiki A, Watanabe Y. Neuroprotective and neurotoxic effects of cyclosporine A on transient focal ischemia in mdr1a knockout mice. Eur J Pharmacol. 2004 Sep 13;498(1-3):115-8.
29. Nakai A. Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia. J Nippon Med Sch. 2007 Jun;74(3):190-201.
30. Nakai A, Shibazaki Y, Taniuchi Y, Miyake H, Oya A, Takeshita T. Role of mitochondrial permeability transition in fetal brain damage in rats. Pediatr Neurol. 2004 Apr;30(4):247-53.
31. Nakatsuka H, Ohta S, Tanaka J, Toku K, Kumon Y, Maeda N, et al. Release of cytochrome c from mitochondria to cytosol in gerbil hippocampal CA1 neurons after transient forebrain ischemia. Brain Res. 1999 Dec 4;849(1-2):216-9.
32. Norenberg MD, Rao KV. The mitochondrial permeability transition in neurologic disease. Neurochem Int. 2007 Jun;50(7-8):983-97.
33. Ogawa N, Tanaka K, Kondo Y, Asanuma M, Mizukawa K, Mori A. The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. Neurosci Lett. 1993 Apr 2;152(1-2):173-6.
34. Ozkisacik EA, Discigil B, Boga M, Gurcun U, Badak MI, Kurtoglu T, et al. Effects of cyclosporin a on neurological outcome and serum biomarkers in the same setting of spinal cord ischemia model. Ann Vasc Surg. 2006 Mar;20(2):243-9.
35. Paschen W. Role of calcium in neuronal cell injury: which subcellular compartment is involved? Brain Res Bull. 2000 Nov 1;53(4):409-13.
36. Phillis JW, Diaz FG, O'Regan MH, Pilitsis JG. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex. Brain Res. 2002 Dec 6;957(1):12-24.
37. Preston E, Webster J. A two-hour window for hypothermic modulation of early events that impact delayed opening of the rat blood-brain barrier after ischemia. Acta Neuropathol. 2004 Nov;108(5):406-12.
38. Puka-Sundvall M, Gilland E, Hagberg H. Cerebral hypoxia-ischemia in immature rats: involvement of mitochondrial permeability transition? Dev Neurosci. 2001;23(3):192-7.
39. Sato M, Horinouchi T, Sakurai M, Murakami N, Sato S, Kato M. Cyclosporin A reduces delayed motor neuron death after spinal cord ischemia in rabbits. Ann Thorac Surg. 2003 Apr;75(4):1294-9.
40. Shiga Y, Onodera H, Matsuo Y, Kogure K. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res. 1992 Nov 6;595(1):145-8.
41. Siesjo BK, Elmer E, Janelidze S, Keep M, Kristian T, Ouyang YB, et al. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl. 1999;73:7-13.
42. Sinigaglia-Coimbra R, Cavalheiro EA, Coimbra C. Protective effect of systemic treatment with cyclosporine A after global ischemia in rats. J Neurol Sci. 2002 Nov 15;203-204:273-6.
43. Tachibana T, Shiiya N, Kunihara T, Wakamatsu Y, Kudo AF, Ooka T, et al. Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg. 2005 Jan;129(1):123-8.
44. Tsuruta S, Matsumoto M, Fukuda S, Yamashita A, Cui YJ, Wakamatsu H, et al. The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits. Anesth Analg. 2006 Jun;102(6):1722-7.
45. Uchino H, Elmer E, Uchino K, Li PA, He QP, Smith ML, et al. Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res. 1998 Nov 23;812(1-2):216-26.
46. Uchino H, Elmer E, Uchino K, Lindvall O, Siesjo BK. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol Scand. 1995 Dec;155(4):469-71.
47. Uchino H, Ishii N, Shibasaki F. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage. Acta Neurochir Suppl. 2003;86:105-11.
48. Uchino H, Minamikawa-Tachino R, Kristian T, Perkins G, Narazaki M, Siesjo BK, et al. Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis. 2002 Aug;10(3):219-33.
49. Uchino H, Morota S, Takahashi T, Ikeda Y, Kudo Y, Ishii N, et al. A novel neuroprotective compound FR901459 with dual inhibition of calcineurin and cyclophilins. Acta Neurochir Suppl. 2006;96:157-62.
50. Vachon P, Beaudry F, Marier JF, Ste-Marie L, Montgomery J. Cyclosporin A in blood and brain tissue following intra-carotid injections in normal and stroke-induced rats. Brain Res. 2002 Jul 5;943(1):1-8.
51. Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ. Cyclophilin D as a drug target. Curr Med Chem. 2003 Aug;10(16):1485-506.
52. Wang X, Carlsson Y, Basso E, Zhu C, Rousset CI, Rasola A, et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci. 2009 Feb 25;29(8):2588-96.
53. Yagita Y, Kitagawa K, Matsushita K, Taguchi A, Mabuchi T, Ohtsuki T, et al. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 1996;59(19):1643-50.
54. Yamaguchi T, Miyata K, Shibasaki F, Isshiki A, Uchino H. Effect of cyclosporin a on immediate early gene in rat global ischemia and its neuroprotection. J Pharmacol Sci. 2006 Jan;100(1):73-81.
55. Yoshimoto T, Siesjo BK. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 1999 Aug 28;839(2):283-91.
56. Yoshimoto T, Uchino H, He QP, Li PA, Siesjo BK. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. Brain Res. 2001 Apr 27;899(1-2):148-58.
57. Yu G, Hess DC, Borlongan CV. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. Brain Res. 2004 Aug 20;1018(1):32-7.
58. Zaidan E, Nilsson M, Sims NR. Cyclosporin A-sensitive changes in mitochondrial glutathione are an early response to intrastiatal NMDA or forebrain ischemia in rats. J Neurochem. 1999 Nov;73(5):2214-7.
59. Zhang YJ, Mei HS, Wang C, Wang YL. Involvement of nuclear factor of activated T-cells (NFATc) in calcineurin-mediated ischemic brain damage in vivo. Yao Xue Xue Bao. 2005 Apr;40(4):299-305.